Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer.
Clinical trial NCT07394946 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07394946
- Sponsor
- Cancer Care Hospital & Research Centre Foundation, Lahore
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-07-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.